Wordt geladen...
Lysosome-targeting agents in cancer therapy
Despite considerable efforts from multiple laboratories worldwide, highly specific inhibitors of autophagy for clinical use are not yet available. Lysosomal inhibitors are being employed instead, in spite of multiple limitations that are summarized herein.
Bewaard in:
| Gepubliceerd in: | Oncotarget |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Impact Journals LLC
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5762500/ https://ncbi.nlm.nih.gov/pubmed/29348815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21451 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|